Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Curcumin is the primary polyphenolic curcuminoid in turmeric (Curcuma longa), constituting roughly 77% of its curcuminoid content. It exerts anti-inflammatory and antioxidant effects primarily by inhibiting NF-κB signaling and suppressing pro-inflammatory cytokine production.
Origin & History
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is the primary bioactive polyphenolic compound extracted from the rhizomes of Curcuma longa L. (turmeric), a perennial plant in the Zingiberaceae family native to South Asia. It is obtained through solvent extraction (e.g., ethanol or acetone) followed by purification, often yielding standardized extracts with 95% curcuminoids.
Research Narrative (Provisional)
A 2024 comprehensive meta-analysis included 103 RCTs (n=7,216) across 42 outcomes, confirming benefits in inflammation (PMID: 39478418). Multiple meta-analyses support curcumin's anti-inflammatory effects, including reduced CRP, IL-6, and TNF-α (PMC9870680, PMID: 30402990), improvements in rheumatoid arthritis (PMID: 41601662), and reduced COVID-19 mortality (PMID: 36640146).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Curcumin is a pure polyphenolic bioactive compound, not a whole food, and therefore contains no meaningful macronutrients (carbohydrates, fats, or proteins) in its isolated form. As a concentrated extract, it is essentially 100% active compound by dry weight when purified. Key bioactive identity: 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, molecular weight 368.38 g/mol, CAS 458-37-7. It is the principal curcuminoid in turmeric (Curcuma longa), typically comprising 77% of the curcuminoid fraction alongside demethoxycurcumin (~17%) and bisdemethoxycurcumin (~3%). In raw turmeric root, curcumin constitutes approximately 2–5% dry weight (roughly 200–500 mg per 10g fresh turmeric). In commercial standardized turmeric extracts, curcuminoid concentration is typically 95% by weight. Bioavailability: Curcumin in its native form is notoriously poorly bioabsorbed — oral bioavailability is <1% due to low aqueous solubility, rapid intestinal metabolism, and rapid systemic elimination. Peak plasma concentration after 2g oral dose is approximately 0.006 µg/mL. Bioavailability is substantially enhanced by: piperine co-administration (20 mg piperine increases absorption by ~2,000%), phospholipid complexes (Meriva®, ~29-fold increase), nanoparticle/liposomal formulations, and lipid-based delivery systems. Primary metabolites include tetrahydrocurcumin, curcumin glucuronide, and curcumin sulfate. No significant vitamin, mineral, or fiber content is present in isolated curcumin form.
Reported Mechanism (Provisional)
Curcumin inhibits the NF-κB transcription factor by blocking IκB kinase (IKK) phosphorylation, thereby preventing downstream transcription of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. It also directly scavenges reactive oxygen species (ROS) and upregulates Nrf2-mediated antioxidant response elements, inducing HO-1 and superoxide dismutase expression. Additionally, curcumin inhibits COX-2 and 5-LOX enzymes, reducing prostaglandin E2 and leukotriene B4 synthesis.
Clinical Narrative (Provisional)
A meta-analysis of 5,870 participants demonstrated significant reductions in C-reactive protein (effect size −0.74), IL-6 (ES −1.07), and TNF-α (ES −1.92) with moderate-certainty evidence. A separate meta-analysis of 6 RCTs (n=244) found significant improvement in rheumatoid arthritis symptom scores compared to placebo or NSAIDs. Bioavailability is a recognized limitation, as standard curcumin has poor intestinal absorption; phospholipid complexes (Meriva), nanoparticle formulations, and piperine co-administration (20 mg enhancing absorption by ~2,000%) meaningfully improve plasma concentrations. Evidence quality across trials is moderate, with heterogeneity in formulations, doses, and outcome measures warranting cautious interpretation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.